Clinical Trials Browser

Leukemia, Myeloid, Acute

Advanced Malignant Solid Tumors

Lung Neoplasms, Ovarian Neoplasms

Biliary Tract Neoplasms

Advanced Gynecological Malignancies

Advanced Solid Tumor (Phase 1)

Non-Muscle Invasive Bladder Neoplasms

Uterine Cervical Neoplasms

Lymphoma, Large B-Cell, Diffuse

Advanced Solid Tumour

Advanced Lung Cancer

Advanced Malignant Solid Tumor

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Small Cell Lung Carcinoma

Non-small Lung Cancer

Advanced Solid Tumor

Advanced Endometrial Cancer

Advanced Endometrial Cancer

Pancreatic Neoplasms

Advanced Solid Tumors

CLDN18.2-positive Advanced Biliary Tract Cancer

Multiple Myeloma

Malignant Solid Tumor

Small Cell Lung Carcinoma

Advanced Extrapulmonary Neuroendocrine Cancer

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

Adenocarcinoma

Breast Neoplasms

Pancreatic Neoplasms

Advanced Solid Tumors

Nasopharyngeal Neoplasms, Recurrence

Clinical Trials

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors

CYTALUX Dose Extension Study

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

A Phase III Study of HMPL-760 in Combination With R-GemOx Versus Placebo in Combination With R-GemOx in Relapsed/Refractory DLBCL

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma

A Study of MHB009C in Patients With Advanced Solid Tumors

INJECTABL-3

SKB500 Combinations in Patients With Small Cell Lung Cancer

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors

Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors

Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors

A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

First-In-Human Study in Participants With Advanced Solid Tumors

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer